supplements for glp-1 Supplement brain cell function and reduce fatigue for those low in B12 Nature Made GLP-1 Companion Health

20 TECOS (2015) did not show an increased risk of HF in patients taking sitagliptin for treatment of type 2 diabetes

Patients with diabetes face additional risk, as dehydration can precipitate diabetic ketoacidosis in susceptible individuals

While the theoretical long-term benefits to health outcomes are welcomed, the short-term cost impact to health insurers must be considered

The most common side effects of tirzepatide are gastrointestinal: Nausea: Reported by 12-33% of participants depending on dose (most common early in treatment) Diarrhea: 12-21% of participants Constipation: 6-11% of participants Vomiting: 5-13% of participants Decreased appetite: Expected therapeutic effect but can be uncomfortable These side effects are typically most intense during the first few weeks at each new dose level and tend to improve as the body adjusts

Figure 4 illustrates some of the findings

*3-month, 6-month, or 12-month Ivm membership is required ($74.99/mo)